WELL Health Technologies (TSE:WELL) Announces Quarterly Earnings Results

WELL Health Technologies (TSE:WELL) posted its quarterly earnings data on Monday. The company reported C$0.11 earnings per share (EPS) for the quarter, FiscalAI reports. WELL Health Technologies had a net margin of 0.25% and a return on equity of 0.44%. The firm had revenue of C$407.40 million during the quarter.

Here are the key takeaways from WELL Health Technologies’ conference call:

• Canadian Clinics reached a CAD 100 million annualized adjusted EBITDA run rate one quarter ahead of schedule. Q3 revenue grew 49%, adjusted EBITDA rose 82%, and same-clinic sales increased 12%, with management citing stronger margins and productivity.
• On a normalized basis, Q3 revenue increased 17% to CAD 407.4 million and adjusted EBITDA rose 20% to CAD 50.9 million, as growth shifted toward higher-margin businesses. Comparisons exclude CAD 17.6 million of Circle Medical revenue deferrals in the prior-year quarter.
• WELL updated 2026 revenue guidance to approximately CAD 1.58 billion, citing acquisition timing, slower second-half M&A, and weakness in U.S. provider staffing. It maintained adjusted EBITDA guidance of CAD 185 million to CAD 195 million.
• The WELLSTAR listing converted about CAD 155 million of preferred-share liabilities into equity, while a CAD 150 million bond offering helped repay convertible debentures and extend maturities to 2031, improving balance-sheet flexibility.
• WELL reported a CAD 135.5 million net loss, including CAD 67.5 million of non-cash impairments and WELLSTAR transaction-related charges; adjusted free cash flow attributable to shareholders was CAD 13.3 million, down from CAD 15.1 million. Management said two of three U.S. asset-sale processes had advanced with focused counterparties, but no binding outcomes were announced.

WELL Health Technologies Stock Up 2.2%

WELL stock traded up C$0.09 during trading hours on Monday, reaching C$4.25. 1,251,405 shares of the stock were exchanged, compared to its average volume of 1,315,458. The firm’s 50-day moving average is C$4.24 and its 200-day moving average is C$4.19. The company has a market cap of C$1.09 billion, a price-to-earnings ratio of 212.50, a PEG ratio of -1.93 and a beta of 0.51. The company has a debt-to-equity ratio of 100.05, a current ratio of 0.80 and a quick ratio of 1.02. WELL Health Technologies has a 12 month low of C$3.58 and a 12 month high of C$5.19.

Analyst Ratings Changes

Separately, TD set a C$8.50 price target on shares of WELL Health Technologies and gave the company a “buy” rating in a research note on Monday, October 5th. Five equities research analysts have rated the stock with a Buy rating. According to MarketBeat.com, the company has an average rating of “Buy” and an average price target of C$7.40.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. (TSX: WELL) is Canada’s largest outpatient healthcare company and a leading provider of technology-enabled healthcare solutions. WELL is building the infrastructure for a healthier Canada, where every patient gets better care, every provider is empowered by AI, and every piece of health data is protected. WELL owns and operates more than 250 clinics in Canada, supporting more than 5 million annual patient visits. Through its subsidiary WELLSTAR, WELL provides electronic medical records, AI-powered clinical tools, patient engagement platforms and IT management services.